Skip Ribbon Commands
Skip to main content
 
ANBI data
Full name of the Institution: The European Society for Blood and Marrow Transplantation
 
Tax identification numbers:
 
-        RSIN  Foundation: 814370822
-        RSIN Association: 804217257
 
Contact details in The Netherlands: Rijnsburgerweg 10, 2333 AA. Leiden, The Netherlands.
email: info@ebmt.org
phone number: +31 71 526 1444
 
Board Composition:
 
-        The Executive Committee:
o        President: Mohamad Mohty
o        Secretary: Rafael Duarte
o        Treasurer: Jürgen Kuball
 
-        Chair of the Scientific Council: Nicolaus Kröger
-        Co-Chair of the Scientific Council: Arnon Nagler
-        Educational Representative of the Scientific Council: Carlo Dufour
-        Registry Representative of the Scientific Council: Chiara Bonini
-        President of the Nurses Group: John Murray
-        EBMT Congress President: Manuel Abecasis
 
The policy and remuneration policy:
 
The Board is the administrative body of the EBMT. It is responsible for all running operations and decisions that are not due to be taken by the General Assembly (see below). The Board consists of the President, the President-Elect, the Secretary, the Treasurer, the President of the division EBMT Nurses Group and four members elected by and from the Scientific Council. The President of the forthcoming EBMT Annual Meeting is elected onto the Board for the year preceding the annual meeting as a non-voting member. Decisions are taken by majority voting. The President has the deciding vote if the vote is otherwise tied. The Members of the Board will receive no remuneration for their work, unless the Genera Assembly Meeting decides otherwise at the time of appointment. Any expenses incurred will be reimbursed in consultation with the Board.
 
Please refer to the EBMT Foundation Constitution and EBMT Association Constitution and EBMT bylaws to more details on the EBMT Policy.
 
The target:
 
The target of the EBMT is well defined in the association’s Mission and Vision:
 
-        Our Mission: “To save lives of patients with blood cancers and other life-threatening diseases by advancing the fields of blood and marrow transplantation and cell therapy worldwide through science, education and advocacy.
 
-        Our Vision:
o        Enhancing the scientific output of the organisation through strong support for the working parties activities to exploit the potential of the registry, and continue generating high quality retrospective and prospective data both in the autologous and allogeneic settings;
o        Collaborating with the different disease-oriented cooperative groups
o        Widening the scope of the Annual Meeting through the incorporation of high level basic and translational research sessions
o        Developing a broad annual education and events agenda in order to address more focused research and clinical trials
o        Advocating for patients before the health authorities in order to maintain a high standard of care and high quality research
 
Report of our activities and financial report:
 
For this information, please refer to the Annual Report​.
 

 News

 
15/11/2017
November 2017 | Vol. 59 - Issue 5 ... Read more >>
18/10/2017
​vaccinations and CMV/HHV6 infections post-HSCT​... Read more >>
17/05/2017
The EBMT implements Elsevier’s MACRO platform to upgrade patient registry.... Read more >>
10/05/2016
​More than 60 EBMT centres have already started entering their related donor data. We want to invite... Read more >>
 

 Events